Detection of minimal residual disease in multiple myeloma and acute leukaemia.

doi:10.1007/BF02993863

Back to search

Article

Detection of minimal residual disease in multiple myeloma and acute leukaemia.

Medical oncology (Northwood, London, England) - 1 Jun 1996

Bakkus M H, Juge-Morineau N, van der Werff ten Bosch J E

Abstract excerpt

The importance of minimal residual disease detection has increased due to the advanced therapeutic protocols available for multiple myeloma and acute leukaemia. High-dose chemotherapy, followed by stem cell transplantation is often used in patients with multiple myeloma. But despite a longer dise...

Topics

Acute Disease
Alleles
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia
Multiple Myeloma
Neoplasm, Residual
Polymerase Chain Reaction

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.